logo

For the Inventor, By the Inventor

Wuppertal, Germany

Martin Scheer

USPTO Granted Patents = 30

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 147(Granted Patents)


Location History:

  • Wuppertal-Elberfeld, DE (1990)
  • Wuppertal, DE (1977 - 2001)

Company Filing History:

goldMedal29 out of 12,160 
 
Bayer Aktiengesellschaft
 patents
silverMedal1 out of 5 
 
Bayer Aktiengsellschaft
 patents

Years Active: 1977-2001

Loading Chart...
30 patents (USPTO):Explore Patents
1. 6323213 - Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives (2001-11-27),
2. 6278013 - Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives (2001-08-21),
3. 6114351 - N-oxides as antibacterial agents (2000-09-05),
4. 5998418 - Enrofloxacine injection or infusion solutions (1999-12-07),
5. 5808076 - Orally administrable formulations of quinolone- or (1998-09-15),
6. 5679675 - 8-amino-10-(azabicycloalkyl)-pyrido�1,2,3-d,e!�1,3,4!benzoxadiazine (1997-10-21),
7. 5508278 - Pyrido[1,2,3-D,E] [1,3,4]benzoxadiazine derivatives (1996-04-16),
8. 5152986 - Preparation and use of ion exchange resins loaded with (1992-10-06),
9. 5145853 - Bactericidal formulations for use in veterinary medicine (1992-09-08),
10. 5073369 - Efomycins as performance promoters in animals (1991-12-17),
11. 4927810 - Efomycin G and it's use as yield promoter in animals (1990-05-22),
12. 4904679 - Pyrrolophenylalkanolamines as animal yield promoters (1990-02-27),
13. 4880840 - Arylethanolhydroxylamines and their use for promoting yield (1989-11-14),
14. 4863939 - Heteroarylethylamine as production promoters in livestock (1989-09-05),
15. 4847291 - Arylethanol-hydroxylamines for promotion of livestock production (1989-07-11),

Title: Martin Scheer: A Pioneer in Pharmaceutical Innovations

Introduction

Martin Scheer is a notable inventor based in Wuppertal, Germany, with a remarkable portfolio of 30 patents. His work primarily focuses on the development of innovative pharmaceutical compounds, reflecting his dedication to advancing healthcare through scientific research and innovation.

Latest Patents

Among his most recent contributions to the field, Scheer has patented a compound titled "Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives." This invention explores novel 8-cyano derivatives that offer significant therapeutic potential. The patent details the general formula for these compounds and describes intermediates useful in their preparation, indicating a thorough understanding of chemical processes involved in pharmaceutical development.

Career Highlights

Scheer's career includes significant tenures at Bayer Aktiengesellschaft, a leading global pharmaceutical company. His experience there has been pivotal in shaping his expertise and innovations within the industry, allowing him to contribute substantially to the development of advanced medicinal compounds.

Collaborations

Throughout his career, Martin Scheer has had the privilege of collaborating with talented individuals such as Friedrich Berschauer and Anno de Jong. These partnerships have fostered a collaborative environment conducive to innovation, allowing for the sharing of diverse ideas and expertise.

Conclusion

In conclusion, Martin Scheer exemplifies the spirit of innovation in the pharmaceutical industry. With a strong background, numerous patents, and impactful collaborations, he continues to contribute to significant advancements in healthcare, showcasing the vital role inventors play in improving global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…